N. Galanakis
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Use and Resistance 2
-
- Antibiotic Resistance in Bacteria 4
- Co-authors
- Helen GiamarellouG. K. DaikosE. DounisJennifer Trofe‐ClarkDeirdre SawinskiEvangelos J. Giamarellos‐BourboulisEmily A. BlumbergRoy D. Bloom
- Journals
- Journal of Antimicrobial Chemotherapy (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)International Journal of Antimicrobial Agents (2 papers)Drugs (1 paper)
- Partner nations
- GreeceUnited States
In The Last Decade
N. Galanakis
16 papers receiving 336 citations
Peers
Comparison fields: 5 of 67
- Molecular Medicine 111
- Applied Microbiology and Biotechnology 43
- Pharmacology 122
- Epidemiology 170
- Clinical Biochemistry 30
Countries citing papers authored by N. Galanakis
This map shows the geographic impact of N. Galanakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Galanakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Galanakis more than expected).
Fields of papers citing papers by N. Galanakis
This network shows the impact of papers produced by N. Galanakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Galanakis. The network helps show where N. Galanakis may publish in the future.
Co-authorship network
The 23 scholars most cited alongside N. Galanakis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 67 | |
| 2 | 2009 | 4 | |
| 3 | 2009 | 7 | |
| 4 | 2008 | 4 | |
| 5 | 2006 | 53 | |
| 6 | 2001 | 8 | |
| 7 | 2001 | 9 | |
| 8 | 1997 | 47 | |
| 9 | 1993 | 1 | |
| 10 | 1989 | 17 | |
| 11 | 1988 | 23 | |
| 12 | Use of intravenous ciprofloxacin in difficult-to-treat infections. | 1987 | 42 |
| 13 | 1986 | 10 | |
| 14 | 1986 | 48 | |
| 15 | Aztreonam versus cefamandole in the treatment of urinary tract infections. | 1984 | 3 |
| 16 | 1984 | 24 |
About N. Galanakis
N. Galanakis is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Pharmacology, Epidemiology and Otorhinolaryngology, having authored 16 papers that have together received 367 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Orthopedic Infections and Treatments (5 papers), Antibiotic Resistance in Bacteria (4 papers), Pneumonia and Respiratory Infections (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Antibiotic Use and Resistance (2 papers), Infective Endocarditis Diagnosis and Management (2 papers) and Antimicrobial Resistance in Staphylococcus (2 papers). The work is most often cited by research in Molecular Medicine (111 citations), Applied Microbiology and Biotechnology (43 citations), Pharmacology (122 citations), Epidemiology (170 citations) and Clinical Biochemistry (30 citations). N. Galanakis has collaborated with scholars based in Greece and United States. Frequent co-authors include Helen Giamarellou, G. K. Daikos, E. Dounis, Jennifer Trofe‐Clark, Deirdre Sawinski, Evangelos J. Giamarellos‐Bourboulis, Emily A. Blumberg, Roy D. Bloom, Θωμάς Τσαγανός and K. Kanellakopoulou. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases, International Journal of Antimicrobial Agents and Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.